Fluidigm Announces Agreement with DNA Software to Offer Secondary CNV Analysis for Biomark HD
PDF Version Combining high-performance automated microfluidics with easy-to-use software to streamline CNV detection for translational and clinical research SOUTH SAN FRANCISCO, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into a non-exclusive distribution agreement with DNA Software, Inc. to provide CopyCount-CNV™ software for use with the Fluidigm Biomark™ HD system. Copy number variation... Read more